Loading provider…
Loading provider…
Urology Physician in New York, NY
NPI: 1558347161Primary Employer
Mskcc Surgery Group
mskcc.org
HQ Phone
Get MD Bernard's Phone Numberphone_androidMobile
Get MD Bernard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
CA State Medical License
1991
NJ State Medical License
2021 - 2027
NY State Medical License
2000 - 2027
NC State Medical License
2021 - 2022

American Board of Urology
Urology
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 1990
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Urology
1992 - 1996
Residency • Surgery
1990 - 1992
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 452 | 592 |
| 2 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 408 | 623 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 112 | 127 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 78 | 82 |
| 5 | 52235Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 62 | 72 |
Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience.
Authors: Guido Dalbagni, Harry Herr, Christopher Tully, Dean Bajorin
Publication Date: 2020-01-22
Comprehensive molecular characterization of urothelial bladder carcinoma
Authors: Mark Soloway, Timothy Triche, Carmen Gomez-Fernandez, Hikmat Al Ahmadie, Ilana Garcia-Grossman, Gordon Mills, Victor Reuter, Merce Jorda, Seth Lerner, Sheldon Bastacky, Bogdan Czerniak, Payal Kapur, Kenneth Aldape, Eila Skinner, Charles Guo, Yair Lotan, Jonathan Rosenberg, Brian Robinson, Wei Zhang, Donna Hansel, Christopher Benz, Benjamin Davies, Tatjana Antic
Journal: Nature
Publication Date: 2014-01-29
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Intervention / Treatment: DRUG: Erdafitinib
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Rockefeller University, Pin Down Bladder Cancer Research Foundation
Intervention / Treatment: DRUG: anti-CD40 antibody 2141-V11
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: therapeutic conventional surgery, PROCEDURE: therapeutic extended lymphadenectomy, PROCEDURE: therapeutic standard lymphadenectomy